Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 5,269	$ 7,040
General and administrative	5,605	6,540
Total operating expenses	10,874	13,580
Loss from operations	(10,874)	(13,580)
Other income (expense), net:
Interest and investment income	119	115
Other income (expense), net	119	115
Net loss	$ (10,755)	$ (13,465)
Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)	$ (0.96)	$ (1.2)
Weighted-average shares outstanding, basic and diluted (in Shares)	11,250,127	11,226,929
Other comprehensive income (loss):
Net unrealized (loss) gain on marketable debt securities	$ (731)	$ (164)
Other comprehensive income (loss)	(731)	(164)
Comprehensive Loss	$ (11,486)	$ (13,629)